Clinical Trial Laboratory Services

Our Clinical Trial Laboratory Services

With Cerba Research’s clinical trial laboratory services, your samples are in safe hands. We offer comprehensive clinical trial laboratory testing, from safety to specialty, ensuring that you meet your objective.

Our capabilities include:

Standard s afety t esting – standard haematology, biochemistry panels, urinalysis, serology & coagulation testing

Molecular biology testing – qPCR, RT-PCR, dd-PCR, RT-PCR, Multiplex PCR amplification, BioFire FilmArray

Lab testing in clinical trials – (incl. a ssay d evelopment & t echnology t ransfer) – biomarker-driven trial solutions

Flow cytometry – BD FACS Canto™ II (12-Color), Cytek Aurora (>40 Colors), BD FACS lyric whole blood, bone marrow, PBMC
Histopathology and anatomic pathology – Multiplex and standard IHC, Immunostaining, ISH/FISH, 200+ biomarkers FFPE, Cryosections Leica, Roche Ventana, RUO/IVD
Genetics/NGS – NGS (WEG, WGS), mutation analysis, MRD, RCL, VCN, Illumina (MiSep, HiSeq, NextSeq, NovaSeq) & Sanger, Nanostring
Microbiology – culture and identification, antibiotic resistance testing, microbiome analysis (sequencing)

Cell Isolations – PBMC, BMMC, CD138+ isolations performed in-house, pre-analytical processing network of labs

ELISA-based Assays – ELISA, MSD S600 Meso Scale Discovery, Luminex, Ella ProteinSimple, Quanterix Simoa HD1

Bioanalysis – PharmacoKinetics, drug performance with PK, PD/ADA, small & large molecules, ELISA-based methods LC-MS/MS

Functional cell-based assays – T-cell activation, ADCC, ELISpot

Virology testing -Virus Culture, TCID50, neutralization assays, inhibition assays, viral load, genotyping & phenotyping

Digital imaging – Transforming visual results into quantifiable data with Halo® and Visiopharm® Software

Genomic Testing

With over 30 years of experience, let Cerba Research support your genomic sequencing and testing ambitions.

Rare Diseases

We facilitate state-of-the-art technology, subject matter expertise, and specialized logistics and operations to accelerate your rare disease development.